Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spyridon Fortis

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
BMC Nephrology|March 27, 2026
The impacts of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on rates of acute kidney injury in hospitalized adults receiving multiple nephrotoxinsMichael Tabet, Mary Vaughan-Sarrazin, Brian C Lund, et al.
American Journal of Respiratory and Critical Care Medicine|November 30, 2023
Reply to Neder, to Ogata <i>et al.</i>, and to GrahamSurya P Bhatt, Arie Nakhmani, Spyridon Fortis, et al.
American Journal of Respiratory and Critical Care Medicine|June 20, 2023
FEV<sub>1</sub>/FVC Severity Stages for Chronic Obstructive Pulmonary DiseaseSurya P Bhatt, Arie Nakhmani, Spyridon Fortis, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 14, 2023
High versus Medium Dose of Inhaled Corticosteroid in Chronic Obstructive Lung Disease: A Systematic Review and Meta-AnalysisParaschos Archontakis Barakakis, Thuonghien Tran, Jee Young You, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 22, 2021
Omalizumab in Asthma with Fixed Airway Obstruction: Post Hoc Analysis of EXTRANicola A Hanania, Spyridon Fortis, Tmirah Haselkorn, et al.
Scientific Reports|March 22, 2020
Low FVC/TLC in Preserved Ratio Impaired Spirometry (PRISm) is associated with features of and progression to obstructive lung diseaseSpyridon Fortis, Alejandro Comellas, Victor Kim, et al.
American Journal of Respiratory and Critical Care Medicine|February 2, 2024
STAR Has Better Discrimination for Mortality than ERS/ATS Chronic Obstructive Pulmonary Disease Severity ClassificationSurya P Bhatt, Arie Nakhmani, Spyridon Fortis, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2022
Beyond Access: Factors Associated With Spirometry Underutilization Among Patients With a Diagnosis of COPD in Urban Tertiary Care CentersArianne K Baldomero, Ken M Kunisaki, Ann Bangerter, et al.
Chest|February 12, 2022
Association of Nonobstructive Chronic Bronchitis With All-Cause Mortality: A Systematic Literature Review and Meta-analysisSpyridon Fortis, Zacariah K Shannon, Crystal J Garcia, et al.
ERJ Open Research|December 10, 2024
Supplementary oxygen efficacy for chronic pulmonary disorders and exertion desaturationParaschos Archontakis Barakakis, Adam Wolfe, Andrei Schwartz, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
BMC Nephrology|March 27, 2026
The impacts of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on rates of acute kidney injury in hospitalized adults receiving multiple nephrotoxinsMichael Tabet, Mary Vaughan-Sarrazin, Brian C Lund, et al.
American Journal of Respiratory and Critical Care Medicine|November 30, 2023
Reply to Neder, to Ogata <i>et al.</i>, and to GrahamSurya P Bhatt, Arie Nakhmani, Spyridon Fortis, et al.
American Journal of Respiratory and Critical Care Medicine|June 20, 2023
FEV<sub>1</sub>/FVC Severity Stages for Chronic Obstructive Pulmonary DiseaseSurya P Bhatt, Arie Nakhmani, Spyridon Fortis, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 14, 2023
High versus Medium Dose of Inhaled Corticosteroid in Chronic Obstructive Lung Disease: A Systematic Review and Meta-AnalysisParaschos Archontakis Barakakis, Thuonghien Tran, Jee Young You, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 22, 2021
Omalizumab in Asthma with Fixed Airway Obstruction: Post Hoc Analysis of EXTRANicola A Hanania, Spyridon Fortis, Tmirah Haselkorn, et al.
Scientific Reports|March 22, 2020
Low FVC/TLC in Preserved Ratio Impaired Spirometry (PRISm) is associated with features of and progression to obstructive lung diseaseSpyridon Fortis, Alejandro Comellas, Victor Kim, et al.
American Journal of Respiratory and Critical Care Medicine|February 2, 2024
STAR Has Better Discrimination for Mortality than ERS/ATS Chronic Obstructive Pulmonary Disease Severity ClassificationSurya P Bhatt, Arie Nakhmani, Spyridon Fortis, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2022
Beyond Access: Factors Associated With Spirometry Underutilization Among Patients With a Diagnosis of COPD in Urban Tertiary Care CentersArianne K Baldomero, Ken M Kunisaki, Ann Bangerter, et al.
Chest|February 12, 2022
Association of Nonobstructive Chronic Bronchitis With All-Cause Mortality: A Systematic Literature Review and Meta-analysisSpyridon Fortis, Zacariah K Shannon, Crystal J Garcia, et al.
ERJ Open Research|December 10, 2024
Supplementary oxygen efficacy for chronic pulmonary disorders and exertion desaturationParaschos Archontakis Barakakis, Adam Wolfe, Andrei Schwartz, et al.
Pageof 9